Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamsulosin versus placebo for urinary tract disorder in women
IRCT20200111046086N1Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in urinary retention and Micturition disorder comparing Tamsulosin with Placebo (2 arms). Primary endpoint: Prevention of urinary retention and urinary complications. Started Aug 2019; status: completed.
02
Drugs
tamsulosin
03
Conditions
urinary retentionMicturition disorder
Beyond the preview
Go deeper on IRCT20200111046086N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200111046086N1.